Explore the vast range of titles available.

The past decade has seen a proliferation of research and publication related to laboratory science and psychiatry. Those advances are now captured in this revised second edition of Laboratory Medicine in Psychiatry and Behavioral Science. Backed by years of clinical practice and research in neuropsychiatry and informed by literature from the National Library of Medicine as well as sources such as the American Society of Health-System Pharmacists Drug Information book, online resources from ARUP Laboratories, and the American Association for Clinical Chemistry, this volume is designed to assist psychiatrists and other behavioral health clinicians in the care of adult psychiatric patients across a wide range of settings. With the same comprehensive approach that was a hallmark of the first edition, this edition features new sections on COVID-19, 22q11.2 deletion syndrome, and DRESS syndrome, as well as updated descriptions of • Laboratory tests, from CT angiography and blood alcohol level to electrocardiograms and a renal function panel• Diseases and conditions, including Alzheimer's disease, autism spectrum disorder, HIV and AIDS, and schizophrenia• Screening and monitoring of psychotropic medications, including benzodiazepines, fluoxetine, naltrexone, and vardenafil Readers can be confident that the provided information is relevant to their daily practice: The included laboratory tests were chosen because they are core for any patient, are novel in medicine, or are particularly pertinent to psychiatry or behavioral health. Similarly, the diseases and conditions described are those for which laboratory tests are important in diagnosis or differential diagnosis; those that are common among psychiatric or geriatric patients; and those that have significant psychiatric, cognitive, or behavioral consequences. With appendixes that contain algorithms, tables, and figures that will aid in understanding and interpreting various laboratory tests and their underlying biology, this volume sets itself apart from any other reference and is an indispensable resource for anyone in general psychiatric practice, from trainees to physician assistants and advanced practice nurses.

Basic Skills in Interpreting Laboratory Data continues to be the most popular teaching text on laboratory data for pharmacy students as well as the go-to reference for pharmacists in therapeutic practice. Now in its seventh edition, Basic Skills has been expanded and updated to cover new drugs, research, and therapeutic approaches.

Medical science has always promised -- and often delivered -- a longer, better life. But as the pace of science accelerates, do our expectations become unreasonable, fueled by an industry bent on profits and a media desperate for big news? Hope or Hype is a taboo-shattering look at what drives the American obsession with medical \"miracles,\" exposing the equipment manufacturers and pharmaceutical companies; doctors and hospitals too quick to order surgery; the politicians; the press; and our own \"technoconsumption\" mindset.

A complete study guide!Use these handy cards for course review now...and exam prep later. More than 500 cards deliver concise, but complete coverage of the major disciplines on the Board of Certification’s content outline—general lab practice; hematology; immunology/serology; immunohematology; clinical chemistry; body fluids; clinical microbiology; and management and education.

Conquer the math skills essential for the laboratory... and reduce the anxieties math often induces! Step by step, skill by skill... you’ll progress from simple to complex calculations, building your proficiencies and testing them along the way. Perfect for classroom, clinical, and professional success!.

Exploring applications in medical research and clinical epidemiology, this text continues to cover important issues related to the design and analysis of reliability and agreement studies. This edition contains a new chapter that describes various models for methods comparison studies as well as a new chapter on the analysis of reproducibility u.

Since 2010, a certified reference material ERM-DA471/IFCC has been available for cystatin C (CysC). This study aimed to assess the sources of uncertainty in results for clinical samples measured using standardized assays. This evaluation was performed in 2015 and involved 7 clinical laboratories located in France and Belgium. CysC was measured in a panel of 4 serum pools using 8 automated assays and a candidate isotope dilution mass spectrometry reference measurement procedure. Sources of uncertainty (imprecision and bias) were evaluated to calculate the relative expanded combined uncertainty for each CysC assay. Uncertainty was judged against the performance specifications derived from the biological variation model. Only Siemens reagents on the Siemens systems and, to a lesser extent, DiaSys reagents on the Cobas system, provided results that met the minimum performance criterion calculated according to the intraindividual and interindividual biological variations. Although the imprecision was acceptable for almost all assays, an increase in the bias with concentration was observed for Gentian reagents, and unacceptably high biases were observed for Abbott and Roche reagents on their own systems. This comprehensive picture of the market situation since the release of ERM-DA471/IFCC shows that bias remains the major component of the combined uncertainty because of possible problems associated with the implementation of traceability. Although some manufacturers have clearly improved their calibration protocols relative to ERM-DA471, most of them failed to meet the criteria for acceptable CysC measurements.

Evidence suggests that medical innovation is becoming increasingly dependent on interdisciplinary research and on the crossing of institutional boundaries. This volume focuses on the conditions governing the supply of new medical technologies and suggest that the boundaries between disciplines, institutions, and the private and public sectors have been redrawn and reshaped. Individual essays explore the nature, organization, and management of interdisciplinary R&D in medicine; the introduction into clinical practice of the laser, endoscopic innovations, cochlear implantation, cardiovascular imaging technologies, and synthetic insulin; the division of innovating labor in biotechnology; the government- industry-university interface; perspectives on industrial R&D management; and the growing intertwining of the public and proprietary in medical technology.

Spatial and molecular characteristics determine tissue function, yet high-resolution methods to capture both concurrently are lacking. Here, we developed high-definition spatial transcriptomics, which captures RNA from histological tissue sections on a dense, spatially barcoded bead array. Each experiment recovers several hundred thousand transcript-coupled spatial barcodes at 2-μm resolution, as demonstrated in mouse brain and primary breast cancer. This opens the way to high-resolution spatial analysis of cells and tissues.